today. Thank afternoon you, Good Peter. and us you for joining thank
Alvarez, will update resolution operational Joining Operating and our an CFO, and will also are and who provide the Chief of CVI/Heights results our convertible our Jonathan the who Wolter, financial me on Eduardo review Officer, performance; debt. today our highlights of our share outlook
to with I we experience joining financial his critical and subject our and are am his components to please and timely a Amyris. very disciplined since CFO and background time leadership to permanent very I'm have our approval, on inside quarter reporting focus announce are and normal title. for we welcome first Jonathan, financials interim cycle Board Welcome, and the reporting will are back for as growth Board. that for into accurate dropping very that Jonathan our us the our also thank third and of him also be – His of great XXXX. from to happy the delivery significant you pleased supporting on
in way. our has challenging This year and it with production, we growth doing remained the delivering our product considerable a a are of volumes solid Yet has history Eduardo our portfolio the really trials and along for has been discuss a business momentum best which This lot in will that record of led and leading customer later. industry. product to has resulted Amyris in with
I continue made we believe resilient us constraints these and capital while to constraints this more efficient, have difficult have grow. our Although made manage, to
believe fourth least exceed $XX business year-to-date with are us We XXXX results outlook that of an having our to at revenue we enable are will for $XXX million quarter pleased already and million. we our in excellent by
than quarter fourth at that is fourth third product much of are in XXX% quarter than continued in revenues this levels record better quarter. have better this year. the volumes the of record result And expected the XXXX production product and Our to
total four touch revenue better be year. and to than moment, so of about for calibrate you than shorter outlook our almost for currently our XXXX can XX%, the more the on a better tracking this is quarter the quarter I'll of Our in revenue double quarter four year. the third anticipated
million. me let business for was Total quarter for of highlights the color million, up some comprised Now third $XX our rounding third on $XX.X remainder the revenue expect for year. about quarter product and what we to million, review revenue provide the $XX the
above product than of well more our for Our target revenue XXXX doubling is XXXX.
revenue product partners. that or many this component collaboration of part are we share our with to we for revenue to customers. have include includes value share long-term royalty product royalties/value always Our structure reference revenue, When pricing for we that product products supply as long-term recorded ship in component our of agreements partners business these component the our and what's product model of the produce
XXXX. million end To $XX.X was revenue put are revenue in revenue total revenue. $XX Total well year this we for in as XXXX the perspective, can so and is our $XX for part expectation you product this to for tracking in product XXXX over product of And at dial million. year-to-date million
to almost in much for as likely product as deliver year the all of revenue this XXXX. of are fourth We quarter
in HMOs, as Clean as drivers our well Today business. Biossance ingredients and business, call. well squalane grouping and and and Aprinnova sweetener ingredients, health our focus our fragrance which our I'll categories cannabinoids, on as our includes on vitamins Beauty, ingredients our which as then second flavor and as two last did includes category brands Pipette growth we
is to of quarter track third Let me Beauty. continue than and third more revenue. XXXX fourth well Beauty with to the quarter start double Clean on Clean the in the perform very already in quarter
for of sales Clean gross $XX year. be a in Beauty to about run We are the for is sales. on approaching million $X Biossance weekly currently in track gross million rate
doubled sales last than times biossance.com this over and year. this about quarter X were Our what daily last quarter are have more they period
last in as fourth biossance.com of sales much in from quarter tracking to the all are We biossance.com. on deliver as year
Jonathan Academy consumer with excellent partnership Clean launch Van our Our achieving are and Ness the engagement feedback. of and
Clean the educate We market. the for benefits thing industry right is meaning to and and ingredients beauty Beauty This Beauty the on to our everybody's are excited of quickly skin. to lead the Beauty. the of is planet clean transition Clean becoming consumers health and help
lower this We level discounting last than dollars with growth are spent. with return achieving advertising much of on better year much and a
We have last ratio our loyalty from also doubled consumer year.
great $X.XX from led quarter the of the about For for has spend quarter in $X.XX example, our XXXX. about Biossance spent to on a is revenue repeat from This along on for $X for every based of return percent first XXXX third for spent to advertising of up first to in of purchases in gone $X every quarter return quarter the with the and assortment customer XXXX repeat growing the in great customers retention of of has XX% fostering brand. This growth clean our skincare Biossance XXXX. third XX% products of
every less spending customer are are getting more buyers. back acquire to customers We new we these of repeat and as
caps growth, with almost and quarter in Our by sales the Keep Sephora in Sephora that XXX year were no the sales in those doubled XXX grew Sephora end which third productivity by sales by of still Biossance XXX%. end average are were smaller products stores stores wall Also with at of the with end deployment the during mind at than growth caps and stores is have weekly this that expectation defined the assortment high cap stores period more out the of our end end that end end a of in caps. there full will XXX stores format. and caps full at
assortment Stores end only sales. end in formats between stores be Drunk all Elephant’s. they and wall that line. our Drunk its sales with Sephora is propel performer full caps they the our in formats. growth the the a where which about believe in we We Biossance XXX Elephant as to the X The great that have and product stores will difference end is sales far the further at productivity limited X.X have line times the level, full full and big placement will will top continued not product at in have store Biossance continues year, with of stores comp revenue of ramp Biossance XXX the caps and organic by from
significant quarter New Zealand, with Korea. and Thailand sales Australia, more and in recently since also and now We South delivered Biossance the have in expansion geographic
geographic You the for can see all how have be our and and caps, years. expansion growth been the will growth continue to sales in digital Sephora Biossance end of next drivers several
million. $XXX rate To Biossance with for today value you at over consider current you somewhere performance the would acquisition and gross in million high $XXX valuation Drunk at multiples growth valued run applying brands quarter million sales Beauty, between $XX Clean like of large annual can help company and recent our Elephant, be Biossance, our
markets We of sale over will our next and over have current believe $X the no XX of interest the in this value and continued time at to months. lead a pipeline billion execution we a potential products,
and do planet. that investment in the now help just mission proven brand right to model and build by Beauty transition and world Clean ingredients are entire the is starting to a We and Our and in the skincare expand. the clean leading to focus and formulas consumer our industry have growth
baby care great brand Pipette Our receiving is response. consumer
over have with averaging of X,XXX five stars. five We ratings XX% consumer over out
same had We at maturity site. activity experienced visitors times This we over pipettebaby.com experienced XXX,XXX over Biossance X the is to have the level. the with
early our channels week now and are sales We of sales we over each are week excellent selling actively performance. seeing across
Baby, as great Amazon We Buy pipettebaby.com Buy Buy in available well along and through Buy walmart.com amazon.com website partners the are Baby, at from channel Dermstore coming and as our weeks. hearing be feedback our and would
our at in half another active in to hero of use with of business retailer brands the a are goal these We ingredient squalane Both XXXX. ingredients launching continues deliver. box squalane of first big negotiations with our retailer and that
as record moisturizer skin so among that effective tests this to trend. our how a of oils. of Beauty more deliver or this This that ingredients is mineral active is Argan squalane ingredient our carrier compared driven it and clinical times volumes absorbable XX as will Clean have the clean in growing effective a We oil, other the year oil effective other by recognition – shown about of Jojoba tests is
is and as serve brands topical an and will other use squalane comes top There future synergy This Biossance it squalane. performing between within offerings. products when our or our to within skincare including that CBD advantage our clear platform CBD
rate be market squalane role a skincare We about at total in to the squalane size for XX% while also XX% are double year-on-year. to market the over increase market of the overall expanding global about year, XX% the next tracking the playing or of big market
our stable continued revenue and growth health In business has fragrance to of flavors and source be a ingredients, and innovation.
hand in advice and and a for leaders and global the today. tastes had and most partners market making great consumer the partners, collaboration us are natural has in expert our the they both CPG helping consumer Our strategies. and and of Firmenich Givaudan great Givaudan the in are like sustainable a tasting understanding entry source companies of have best on sweetener it market formulate an preferences. and Not go-to-source only trends sweetener market deep are
There have along natural America of now of with with also avoid flavor very formulation orders since flavor is in the the and Latin to sweetener a do that synergy significant are first from cannabinoids, now as in to continue our traction our need well. products tastes like our infused use enhancing expertise we opportunities often sweetener tasting stainable to a beverage and best largest zerocalorie off formulations. gained Purecane and sweetener food stevia sweetener several have for agent received in We Purecane sweetener users and any which cannabinoids. cannabinoids has with our converting
from are that brands North innovators. have These America, with industry are the and switching we early to. leaders are smaller great that consumers brands sales interest In products disrupting in
will We leaders to stage future markets in the of sweeteners. our advanced vertical nutrition also that to drivers become key from negotiation revenue in have specific with bakery
at the As Eduardo batch. have will that this orders from next cover, for and all volume out we time have sold we have production the produced already
category. learnings and of part very and of and us significant we breakthroughs during also year. product year much These now scale our leadership are learnt last about this mostly this and behind are the through have the We the this excited early continued in achieved progress up
Our make life choice a process the launching Purecane month Consumer to consumers and is excited are provide of this brand to their healthy in sweeter. we
and are plan. We program development are cannabinoid pleased ahead with very of our
conditions regulatory track are and commercially on We are assuming cannabinoid CBD scale another to XXXX, met. in
in LAVVAN Our quarter. expect progress have of The starting two and than deliver better industry. very expected to guidance. track leading CBD for been excellent They first the molecules samples cannabinoid the of is has and early in experienced executive delivering team early including formulation we and testing development insight record a
that companies. confident this highly both profitable for We will be are
about the LAVVAN's that it margins. you What of can based production I on have margin and structure. is Some is asked share royalty profit essentially business
In addition, we to minimums protect Amyris’ certain and have LAVVAN's and do controls returns.
the and market. XXth market. end sustainable Amyris This and on safe cost first it's a say sustainably to any ingredients highly enabler product will that in what is will highest natural products fermentation-based, for represent a source safely, efficacy to two the based both brands demanding, and consumer has cannabinoid for cannabinoids globally of think are pure be parties with the scaled I most fact it that successfully that the source see the the the that fermentation XXth that supply deliver is doing confidence time of lowest cannabinoid key consumers
leadership be product another brands to clean a No that sustainable delivering partners. chemistry point will in market and consumers, our natural, It Compromise of delivers our proof
with skincare to certain carve-outs ingredients. for in have We beverage the on own and LAVVAN with segments our agreement Amyris serve cannabinoid
As you this imagine, as is applicable beverage Aprinnova as Biossance serving well and to leading companies. can
beverage two supply top regarding large CBD opportunities. are discussions very companies in We with scale
adding amount is be one our will private the were purity and to lead. a at consumers. that to CBD times can can found those one need XX.X LegitScript This companies companies importance CBD quality online winning study exactly comes recent growing from product consistent by XX% even the with assure fermentation and purity allowable it XXX provide. When that's products, of at reduced what and A least U.S. contained that regulation, noncompliant merchants products costs
label. purity, and – are says a and safe scalability dependable it a less market that getting superior The company they assuring high on for more they ingredients risk what offer and ready is cannabinoid what can that are the quality, exactly production consumers with on getting providing
synthetic view technology. of successfully will be multiple to we lower We opportunity commercially pure scale most the from as biology canabinoids the fermentation continue valuable cannabinoids businesses. one first to that belief our our The highly costs, company
begin me summarizing. let Now
We our key the in are leading and delivering on portfolio our have industry. strategic goals
where are; with volatile goals first, extremely markets commodity exit control. have strategic no we Our pricing
Number health, a and more a this leading natural beauty, portfolio two, We resulting products simpler sustainable consumers. have the or done trend in focused for mega meeting of and for nutrition clean and the products we where this have one are call product, the the one's. of in leading industry. markets investing to we solution we our where strategy We number customer number and partner are delivering
better the current or outlook X and Next, markets growth where is at times GDP.
markets there a us consumer with. win This enables where Next, sustainable be leading trend business. mega have a we the to platform to where is technology
growth value consumer Compromise Lastly, markets the access to to can we leader. proposition have and enables that where a No be the execute us
where impact we want to We bets big deliver make have mega matter. to and that capability global the win issues for
of examples some are our Here where focuses.
First, we lead world. for strategy sugar to reduction want the the
need We an population for replacement sustainable want and safely. opioids. we a for do we want aging to and create this pain Secondly, to management anxiety
and to clean industry harm than then lastly, world perform deliver beauty best don't Pipette a is beauty people the we on a And Clean best No This and the products alternative is or do our children a they use better without need want planet. where planet. want for They that we clean safest our are delivering to move to our we Compromise, ingredients our babies. to for deserve and harm. future performing the Beauty. Thirdly, the and promise
measure our for shared you strategic with metrics clear progress. you We some to
better a the double year. of full are Let this recurring to and million would these. you revenue for We end year. that year revenue doing of the to us next said about product and expect should for exceed that builds year-to-date with on me expectation better tracking said we some We've go over strong base or we $XXX that
a doubling We on clear track path this this million and do to next over the to by year are year. of again $XXX end that with
history gross we program. are where potential that with over program scales. this and the control destiny. and vitamin said from with more in on the of our sales simplify to for we much millions our expected had as business our and We've replace technology in our slightly significantly mid we value E of We high achieved market from enabled place hundreds largest and a for exit or be royalties We would product the XX% has more point This It's provided contract will a cannabinoids than volatile annual portfolio. more R&D E to recurring vitamin revenue we around our than range highly XX% us single we a market better. has to it margin the track a
frequently is is Intrexon public asked where the in others how very direct have a This difficult, base. get we We lower we sector. only against cost our competitor that's compare
We are very and portfolio different growing of markets are much financial we performance. at rate delivering in that a strong term significantly nearer higher have a
way the to is market. private it other compare Our
market direct is determine a data recent on Ginkgo burning of the competitor from biggest Our their private Bioworks. level Based cash. in higher we can are they fundraising, public
have revenue. three that of We XXXX revenue all will Ginkgo’s markets each than more do
quarter. revenue almost our XXXX We are there third total in
rate. We are growing a much at higher
positions leading growing. billions in and strategic that dollars TAM have in are have of markets We
reach is million our they million this operations need from our generation cash estimate positive of coming new will at $XXX to achieving run are looking that in while current of year. performance, in best investment Our $XXX business rate to we
doing we year. next has together we that's what on these a going our industry are we been reality all the and We competition will hopeful, we against sheet better really balance and of be business, appreciate what they're Our the our strongly the we've out working everybody. making improve world into biggest and I'm for year most of been this negative the and equity that companies the and make work respect to and importantly, believe competitors value
are from we We've monetized our longer some also where to we number Amyris. participate cash technology in we monetized future. that licenses, for To-date, have generated these farnesene the million through These Europe, and concern diesel products of heard combination one, Total over economics. are future two we can selling markets investors two The E to renewable which $XXX of in Vitamin DSM. from to no
have have continue hundred We access term long several markets where the hundreds proof-of-concept of where molecules, we to to complete have additional and revenue streams. we
last long you three is is, whether points. The data give simple address sustainable term. today question our I’ll I'll business competitive
We who and expanding have our over products quarter. X,XXX large buying globally customers, today are every
We who have doubling $X customers, annually years over that year-on-year. over and have annually. and Most million each growing generate over million of products generate over $X annual least are of these are XX of for our at been XX% each commercial most currently at revenue two
We the efficiently. sustainable with have is our business a advantage fastest strategic is portfolio most a growing that the to that sector in grow
Our fourth quarter is starting very well.
The a rate million of are revenue of year can around for about run full XXXX. million $XX for be quarter We of most extrapolated total and $XXX tracking fourth into it recurring.
year Our full continuing gross guidance. or midpoint slightly trend XX% our towards the is XX% the to for margin to of higher
We expect expand XXXX. into margin to continue the gross
believe $XX implemented $XX year's already million year. next sold COGS our cost have We volume, lower our by would million on actions of almost goods and this reduce for we that by
will these more in Eduardo cover detail.
EBITDA And After for ensure, to outlook will Eduardo deliver full into continuing in performance Eduardo and an steps I'll year provide continued detailed XXXX. strong XXXX. margin deliver Our very updates, and operational markets Jonathan growth. and their our our provide performance we core cover improvements to positive are a
now to me turn Eduardo. Let Eduardo?
